BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Liver
,
Amniocentesis
,
Clofibrate
,
rs2300478
,
FGF21
,
Apoptosis
,
Allergy to pollen
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
IL-29
(gene)
Summary
General Info
Body Atlas
Most Correlated Tissues
Ascending colon
Rectum colon
Transverse colon
Sigmoid colon
Cecum
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Brucellosis
Zika virus disease
Disease caused by rickettsiae
Disease due to Paramyxoviridae
Ebola virus disease
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
RNA Cap Analogs
Cyclic guanosine monophosphate-adenosine monophosphate
Poly I-C
DNA, Double-Stranded
GW9508
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
MIR340
PCSK9
TRIM8
HDLBP
MIR1290
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Loading...
Explore Curated Studies Results
Literature
Most Relevant Literature
IFNL1 rs30461 polymorphism as a risk factor for COVID-19 severity: A cross-sectional study.
Evaluation of exosomes encapsulated recombinant Interleukin-29 for its in vitro anticancer studies.
Interleukin-29 Accelerates Vascular Calcification via JAK2/STAT3/BMP2 Signaling.
Up and away with cervical cancer: IL-29 is a promising cytokine for immunotherapy of cervical cancer…
Systematic levels of IL-29 and microRNA185-5p were not associated with severe COVID-19 in the Irania…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Study of PEG-rIL-29 (or PEG-IFN Lambda) in Subjects With Chronic Hepatitis C Virus Infection
Efficacy and Safety Study of PEG-rIL-29 Plus Ribavirin to Treat Chronic Hepatitis C Virus Infection
Low-dose IL-2 in Established T1D - The "PROREG" Study
Safety and Biological Activity of TroVax® Vaccine Given With IL-2 in Renal Cell Carcinoma
Maintenance Therapy With Ceplene® (Histamine) and IL-2 on Immune Response and MRD in Acute Myeloid L…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ